Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 113

1.

A randomized evaluation of the effects of six antipsychotic agents on QTc, in the absence and presence of metabolic inhibition.

Harrigan EP, Miceli JJ, Anziano R, Watsky E, Reeves KR, Cutler NR, Sramek J, Shiovitz T, Middle M.

J Clin Psychopharmacol. 2004 Feb;24(1):62-9.

PMID:
14709949
2.

A thorough QTc study of 3 doses of iloperidone including metabolic inhibition via CYP2D6 and/or CYP3A4 and a comparison to quetiapine and ziprasidone.

Potkin SG, Preskorn S, Hochfeld M, Meng X.

J Clin Psychopharmacol. 2013 Feb;33(1):3-10. doi: 10.1097/JCP.0b013e31827c0314.

PMID:
23277250
3.

The safety and pharmacokinetics of quetiapine when coadministered with haloperidol, risperidone, or thioridazine.

Potkin SG, Thyrum PT, Alva G, Bera R, Yeh C, Arvanitis LA.

J Clin Psychopharmacol. 2002 Apr;22(2):121-30.

PMID:
11910256
5.

Corrected QT changes during antipsychotic treatment of children and adolescents: a systematic review and meta-analysis of clinical trials.

Jensen KG, Juul K, Fink-Jensen A, Correll CU, Pagsberg AK.

J Am Acad Child Adolesc Psychiatry. 2015 Jan;54(1):25-36. doi: 10.1016/j.jaac.2014.10.002. Epub 2014 Oct 16. Review.

PMID:
25524787
6.

Retrospective cohort study of diabetes mellitus and antipsychotic treatment in a geriatric population in the United States.

Feldman PD, Hay LK, Deberdt W, Kennedy JS, Hutchins DS, Hay DP, Hardy TA, Hoffmann VP, Hornbuckle K, Breier A.

J Am Med Dir Assoc. 2004 Jan-Feb;5(1):38-46.

PMID:
14706127
7.

Sex differences in the effect of four second-generation antipsychotics on QTc interval in patients with schizophrenia.

Suzuki Y, Sugai T, Fukui N, Watanabe J, Ono S, Tsuneyama N, Saito M, Someya T.

Hum Psychopharmacol. 2013 May;28(3):215-9. doi: 10.1002/hup.2309. Epub 2013 Apr 2.

PMID:
23553637
8.

Analysis of the QTc interval during olanzapine treatment of patients with schizophrenia and related psychosis.

Czekalla J, Beasley CM Jr, Dellva MA, Berg PH, Grundy S.

J Clin Psychiatry. 2001 Mar;62(3):191-8.

PMID:
11305706
9.

The QTc interval and its dispersion in patients receiving two atypical antipsychotics.

Correll CU, Frederickson AM, Figen V, Ginn-Scott EJ, Pantaleon Moya RA, Kane JM, Manu P.

Eur Arch Psychiatry Clin Neurosci. 2009 Feb;259(1):23-7. doi: 10.1007/s00406-008-0829-4. Epub 2008 Jun 20.

PMID:
18574608
10.

Factors affecting drug concentrations and QT interval during thioridazine therapy.

Thanacoody RH, Daly AK, Reilly JG, Ferrier IN, Thomas SH.

Clin Pharmacol Ther. 2007 Nov;82(5):555-65. Epub 2007 Apr 25.

PMID:
17460606
11.

Antipsychotic drugs and QT interval prolongation.

Zareba W, Lin DA.

Psychiatr Q. 2003 Fall;74(3):291-306. Review.

PMID:
12918603
12.

Risperidone treatment in elderly patients with dementia: relative risk of cerebrovascular events versus other antipsychotics.

Finkel S, Kozma C, Long S, Greenspan A, Mahmoud R, Baser O, Engelhart L.

Int Psychogeriatr. 2005 Dec;17(4):617-29. Epub 2005 Oct 5.

PMID:
16202186
13.

EEG abnormalities associated with antipsychotics: a comparison of quetiapine, olanzapine, haloperidol and healthy subjects.

Amann BL, Pogarell O, Mergl R, Juckel G, Grunze H, Mulert C, Hegerl U.

Hum Psychopharmacol. 2003 Dec;18(8):641-6.

PMID:
14696024
14.

Metabolic changes associated with second-generation antipsychotic use in Alzheimer's disease patients: the CATIE-AD study.

Zheng L, Mack WJ, Dagerman KS, Hsiao JK, Lebowitz BD, Lyketsos CG, Stroup TS, Sultzer DL, Tariot PN, Vigen C, Schneider LS.

Am J Psychiatry. 2009 May;166(5):583-90. doi: 10.1176/appi.ajp.2008.08081218. Epub 2009 Apr 15.

15.
16.

Atypical antipsychotic drugs and diabetes mellitus in a large outpatient population: a retrospective cohort study.

Østbye T, Curtis LH, Masselink LE, Hutchison S, Wright A, Dans PE, Schulman KA, Krishnan RR.

Pharmacoepidemiol Drug Saf. 2005 Jun;14(6):407-15.

PMID:
15372671
17.

QTc changes after 6 months of second-generation antipsychotic treatment in children and adolescents.

de Castro MJ, Fraguas D, Laita P, Moreno D, Parellada M, Pascual D, Alvarez M, Merchán-Naranjo J, Rapado M, Giráldez M, Leiva M, Arango C.

J Child Adolesc Psychopharmacol. 2008 Aug;18(4):381-3. doi: 10.1089/cap.2007.0115. No abstract available.

PMID:
18759648
18.

Effectiveness of antipsychotic treatments for schizophrenia: interim 6-month analysis from a prospective observational study (IC-SOHO) comparing olanzapine, quetiapine, risperidone, and haloperidol.

Dossenbach M, Erol A, el Mahfoud Kessaci M, Shaheen MO, Sunbol MM, Boland J, Hodge A, O'Halloran RA, Bitter I; IC-SOHO Study Group.

J Clin Psychiatry. 2004 Mar;65(3):312-21.

PMID:
15096069
19.

QTc interval lengthening is related to CYP2D6 hydroxylation capacity and plasma concentration of thioridazine in patients.

LLerena A, Berecz R, de la Rubia A, Dorado P.

J Psychopharmacol. 2002 Dec;16(4):361-4.

PMID:
12503836
20.

Effects of Oral Ziprasidone and Oral Haloperidol on QTc interval in patients with Schizophrenia or Schizoaffective disorder.

Miceli JJ, Tensfeldt TG, Shiovitz T, Anziano R, O'Gorman C, Harrigan RH.

Pharmacotherapy. 2010 Feb;30(2):127-35. doi: 10.1592/phco.30.2.127.

PMID:
20099987

Supplemental Content

Support Center